 |
|
|
|
 |
egories |
 |
 |
New Addition |
 |
|
|
 |
Details: |
 |
|
[CNN]
Sponsored Links:
|
| URL: |
http://cnn.com/2004/BUSINESS/02/16/sanofi.aventis.reut/index.html
|
| Title: |
CNN.com - Sanofi bullish before Aventis bid - Feb. 16, 2004 |
| Description: |
CNN.com - Sanofi bullish before Aventis bid - Feb. 16, 2004. French drug maker Sanofi-Synthelabo posted a slightly stronger-than-expected rise in 2003 net profit on Monday and offered a bullish view of its pipeline of new drugs as it sought to win support for its hostile takeover bid for rival Aventis. |
| Specialized in: |
|
|
 |
Popular Sites |
 |
 |
Related Press |
 |
Forexpros.com are proud to unveil their full collection of real-time trading tools (Popularity: ): These are some of the most advanced tools you’ll see in one place on the web and they’re totally free ...
Frost & Sullivan: Big Guns with no Bullets to Fire - Intel, Motorola, Sony Ericsson, Nokia, Apple, Samsung, Google and Microsoft (Popularity: ): After a devastating end to 2008, the future is looking bleak. At the start of 2009 the mobile industry is ...
New Study Reveals Radiation Treatment Less Likely for African American Women Fighting Breast Cancer (Popularity: ): According to a new study, African American women with breast cancer who have a lumpectomy are less likely to receive ...
Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients (Popularity: ): Genomic Health, Inc. (Nasdaq: GHDX) today announced results from two studies demonstrating that quantitative reporting for HER2 gene expression, as ...
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel (Popularity: ): A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk ...
|
 |
Related Articles |
 |
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|